相关实验视频
Updated: Jun 14, 2025

09:29
Signal Attenuation as a Rat Model of Obsessive Compulsive Disorder
Published on: January 9, 2015
15.4K
痴呆症中的强迫症症状:系统性审查与元分析
Filipe Peste Martinho1, Tiago Filipe Ferreira1, Daniela Magalhães1
1Hospital Prof. Dr. Fernando Fonseca, Amadora, Lisbon, Portugal.
L'Encephale
|September 7, 2024
概括
痴呆症中强迫症症状很常见,影响35.3%的患者,特别是那些患有前性痴呆症的人 (48.4%). 这一元分析强调了对痴呆症患者这些症状进行更好的评估工具的需要.
科学领域:
- 神经科学是一个神经科学.
- 精神病学是一个精神病学.
- 老年学是一门学科.
背景情况:
- 痴呆症是一种普遍的综合征,其特点是认知缺陷和功能障碍.
- 神经精神症状,包括强迫症症状 (OCS),经常与痴呆症同时发生.
研究的目的:
- 进行元分析以确定痴呆症患者中OCS的患病率.
- 描述在痴呆症中观察到的痴迷和强迫症类型.
主要方法:
- 在MEDLINE,CENTRAL和Psycnet数据库中进行了系统的搜索,直到2023年3月.
- 乔安娜·布里格斯研究所的批判性评估清单被用于质量评估.
- 获取和分析了流行数据和OCS类型.
主要成果:
- 包括37个队列的30项研究,分析了643篇最初选的文章.
- 痴呆症中OCS的总体患病率为35.3% (95% CI:23.1-47.6%).
- 与其他类型痴呆症 (17.6%,95% CI:9.1-26.2%) 相比,OCS在前性痴呆症 (48.4%,95% CI:29.8-67.0%) 中更为普遍.
- 常见的痴迷包括对称性 (28.6%) 和身体问题 (20.0%);常见的强迫症包括检查 (27.4%) 和积 (27.8%).
结论:
- 在痴呆症,尤其是前性痴呆症中,OCS特别普遍.
- 流行率估计中的异质性可能与诊断标准和评估方法有关.
- 需要改进,标准化的仪器,以对痴呆症患者进行可靠的OCS评估.
相关概念视频
Obsessive-Compulsive Disorder
70
Obsessive-compulsive disorder (OCD) is a mental health condition characterized by recurrent obsessions, compulsions, or both, which consume significant time and interfere with daily functioning. Obsessions involve persistent, intrusive, and unwanted thoughts, images, or urges that evoke anxiety. Common examples include irrational fears of contamination or harm. Compulsions are repetitive behaviors or mental acts performed to reduce the anxiety caused by obsessions. For instance, individuals...
70
Diagnostic and Statistical Manual of Mental Disorders (DSM)
49
The Diagnostic and Statistical Manual of Mental Disorders (DSM) serves as the primary classification system for mental health disorders, providing standardized diagnostic criteria for clinicians and researchers. First published by the American Psychiatric Association (APA) in 1952, the DSM has undergone several revisions to reflect evolving psychiatric understanding. The fifth edition, DSM-5, released in 2013, introduced key updates that expanded diagnostic categories and modified diagnostic...
49
Alzheimer's Disease: Overview
454
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
454
Personality Disorders: Dependent and Obsessive-Compulsive
38
Dependent personality disorder and obsessive-compulsive personality disorder are two separate psychological conditions that influence behavior, relationships, and overall life functioning. Though both involve maladaptive behaviors, their core characteristics and motivations differ significantly.
Dependent Personality Disorder
Dependent personality disorder is characterized by an excessive reliance on others to manage various aspects of life. Individuals with this disorder often struggle...
Dependent Personality Disorder
Dependent personality disorder is characterized by an excessive reliance on others to manage various aspects of life. Individuals with this disorder often struggle...
38
Depressive Disorders: MDD and Dysthymia
70
Depressive disorders are a group of mental health conditions characterized by pervasive feelings of sadness, diminished pleasure in life, and a significant impact on daily functioning. These conditions are most prevalent in individuals during their 30s and affect women at twice the rate of men. Contrary to popular belief, younger individuals are generally more susceptible to these disorders than older adults. Two key types of depressive disorders include Major Depressive Disorder (MDD) and...
70
Alzheimer's Disease: Treatment
170
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
170

